Pharma Journalist - Page 31 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Updates Safety Label for ELEVIDYS Gene Therapy for Duchenne Muscular Dystrophy

FDA Approval of KOMZIFTI Marks Major Step for Hard-to-Treat AML

UK Approves Monthly Maintenance Dosing for Alzheimer’s Drug Leqembi

Mangoceuticals Launches Direct GLP-1 Access Programs for Affordable Weight-Loss Care

MeiraGTx Partners with Eli Lilly in $475M Gene Therapy Deal to Restore Vision in Children

Insilico Medicine Expands AI Drug Discovery Partnership with Eli Lilly in $100M Collaboration

SanegeneBio Partners with Eli Lilly in $1.2 Billion RNAi Metabolic Disease Collaboration

Harbour BioMed, Evinova Partner to Advance AI-Driven Biologic Drug Development

Novartis Opens New Radioligand Therapy Manufacturing Facility in California to Boost U.S. Cancer Treatment Capacity

Lyell Immunopharma Boosts Solid Tumor Pipeline with Acquisition of Promising CAR T Therapy for Colorectal Cancer